Your GGT Blood Test Is Normal. That Is Not the Same as Healthy

A GGT blood test measures gamma-glutamyl transferase. Cells raise this enzyme under oxidative strain to keep up their glutathione defenses. The normal range is built to catch disease that has already arrived. The risk of diabetes and cardiovascular death climbs well inside it.

A GGT blood test comes back at 30 and the report calls it normal. A cohort study followed more than nine million Korean adults. For women, the highest third of GGT began at just 21 IU/L. Those women carried more risk of dying from any cause than women in the lowest third. The lab and the cohort are reading the same number two different ways.

The video above is Chapter 5 of The Angry Gut, by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes, about the fat and the alcohol a gut can ship to a liver. What follows stays with one line on your panel. What is GGT doing inside a cell? How far does its signal reach? Where does it stop being useful?

What does a GGT blood test measure?

Gamma-glutamyl transferase is usually read as a flag for drinking or a blocked bile duct. Its day job is antioxidant supply. The enzyme sits on the outer surface of the cell. It breaks down glutathione outside the cell. That frees cysteine, which the cell needs to rebuild its defenses. A cell under oxidative strain raises GGT because that buys it resistance.

Here I have to correct what I was taught. For about fifty years the enzyme was described as the engine of an amino acid transport cycle, and that version is still in textbooks. Under real conditions it is not a transporter at all. It cuts a bond, releases glutamate, and the leftover fragment feeds the surface enzymes that free cysteine. Knockout mice settled it: the job is cysteine supply (Hanigan, 2026). The older story leads people to misread their own results.

Picture a liver cell packed with fat. Endotoxin and gut-made alcohol pour in through the portal vein. The cell burns glutathione faster than it can replace it. So it puts up more GGT to cope. The number climbs while the cell is still alive and fighting.

Is a GGT in the normal range healthy?

Reference ranges are built to catch disease that has already arrived. Risk curves tell a different story. One analysis pooled nine cohorts and 527,589 people. Cardiovascular death rose by 1.10 for every 10 units per liter of GGT. The authors stated plainly that risk climbs inside the reference interval (Wang et al., 2017).

The diabetes signal is just as early. A British study followed 3,500 men aged 60 to 79 without diabetes for five years. There were 100 new cases. After adjusting for body mass index, the top quarter of GGT carried a risk of 3.68 against the bottom quarter. Adding insulin resistance shrank it to 2.69, and it held (Wannamethee et al., 2005).

The enzyme also rides alongside liver fat. In the Korean cohort, people with a high fatty liver index went from 1.6% to 11.5% to 47.7% across rising thirds of GGT. The death signal survived adjustment for that index (Cho et al., 2023). One wrinkle for women: their curve was a shallow J, and the lowest values were not the safest.

Does GGT matter if you never drink alcohol?

The obvious challenge is drinking. Heavier drinkers have higher GGT, and people under-report alcohol. A pooled Japanese analysis handled that by design rather than by statistics. Seven cohorts gave 15,987 men and 25,053 women aged 40 to 79. They were followed an average of 8.7 years. The analysis was limited to people who had never drunk (Li et al., 2016).

In never-drinking women, each standard deviation of GGT carried a risk of 1.81 for coronary death and 1.30 for all cardiovascular death. In never-drinking men, cardiovascular death overall ran 1.43, while the coronary estimate was null at 1.04. The signal survives removing alcohol, more convincingly in women than in men. Never-drinking was self-reported, which is the fair limit.

What GGT cannot tell you

It is not specific. Obesity is its most common cause, ahead of alcohol. Adding GGT to a first-line liver panel roughly doubles the share of adults flagged abnormal, from around 15% to about 30% (Newsome et al., 2018). British guideline writers kept it anyway, because the trial used against it left out the fatty liver and alcohol patients who account for 90% of liver deaths.

It does not improve a risk score. In three British surveys, GGT predicted cardiovascular death at 1.43 per standard deviation in people with diabetes. It was 1.27 in those without. Yet knowing it added nothing beyond standard risk factors (Kengne et al., 2012). A real signal can add nothing to a score that already carries the same information by another route.

And it is not the engine. Genetically higher GGT showed no link to diabetes, at an odds ratio of 0.88. It showed none to coronary disease, at 1.08. ALT run through the same method came out at 2.99 per doubling for diabetes (Liu et al., 2016). GGT reports the strain. Lowering the number by itself fixes nothing, the same way unplugging a smoke alarm leaves the kitchen burning.

How do you lower GGT? Change the delivery, not only the calories

If GGT reports oxidative load on a fat-filled liver, repair means changing what feeds the load. Biology supplies two feeds through the portal vein: inflammatory bacterial fragments, and fermentation products that become liver fat. Economics supplies a third: cheap subsidized sweetener in nearly every packaged meal. It feeds gut bacteria first.

The same substrate can help one liver and load another. In adults with fatty liver given the fermentable fiber inulin for six weeks, liver fat rose from 20.9% to 26.8% in that arm (Chambers et al., 2019). Gut bacteria ferment inulin into acetate. Acetate is a fat-building fuel shipped straight to a liver already primed to make fat. The trial was small and its main comparison was null, but the direction is the lesson.

Nutrient supply matters in the other direction too. In a supervised study, 15 healthy women ate controlled meals. Their choline was cut to under 50 milligrams a day. A rise in liver fat above 28% was set in advance as a reason to stop. Some developed fatty liver, and it resolved when choline returned. Which women were affected was predicted by their gut bacteria before the diet began (Spencer et al., 2011). Typical American intake runs a median of 284 milligrams a day against a recommended 550. That is a conversation for your physician about diet, not a supplement to buy.

This is terrain work. The fuel side and the insulin side are traced in how the modern plate inflames the brain, and the wall that decides how much reaches the portal vein is the subject of the previous chapter on measuring gut permeability.

How to read your own GGT

One reading is a snapshot. Five readings across ten years are a trajectory. Pull every GGT result you can find. Look for drift inside the reference range, because that drift is the signal the cohorts describe. Read it the way you read a resting heart rate. It tells you how hard the system is working, and it moves when the terrain moves.

For the wider panel, see the metabolic audit and which biomarkers earn a place. Every cohort, every hazard ratio and every limit above is set out study by study in the Chapter 5 Deep Dive.

Frequently asked questions

What is a normal GGT level?

Labs print a reference interval, but risk is not flat inside it. Pooled cohorts show cardiovascular death rising with GGT well within that interval. In one very large Korean cohort, the highest-risk third for women started at 21 IU/L. A value inside the range is a different statement from a healthy value. How that gap shows up in other routine markers is covered in our guide to hsCRP and inflammation markers.

What causes high GGT if I do not drink?

Obesity is the most common cause, ahead of alcohol. GGT rises when cells face oxidative stress, and a liver loaded with fat and receiving bacterial products from the gut is under exactly that strain. Studies limited to people who never drank still found GGT tied to cardiovascular death. So a raised value deserves a workup, not a shrug. Where that inflammatory strain begins is explained in why the same treatment works in one body and fails in another.

Does GGT show fatty liver?

It tracks it closely but does not diagnose it. In one cohort, the share of people with a high fatty liver index rose from 1.6% to 47.7% across rising GGT. Ultrasound can miss fat until more than 30% of liver cells are loaded. So a raised GGT with metabolic risk factors can mean fatty liver behind a normal scan. The gut side of that story continues in the next chapter on a bowel that cannot absorb.

Can you lower GGT naturally?

The number is a gauge, so the aim is to change what it reports. Genetic studies show GGT itself does not cause diabetes or heart disease. That means chasing the value alone misses the point. The target is what the gut delivers to the liver: meal pattern, sugar load, and fermentable fuel. Work through it with your physician. Why no procedure outruns that terrain is argued in you cannot out-inject a broken metabolism.

What does it mean if your GGT is high?

It means cells are under oxidative strain and are putting up more of the enzyme to keep their glutathione defenses supplied. Obesity is the most common cause, ahead of alcohol. A fat-loaded liver receiving bacterial products from the gut is a typical source. GGT reports the strain. It does not cause disease. So the useful response is to find and change what is feeding it.

Sources

1. Cho, E. J., Jeong, S.-M., Chung, G. E., Yoo, J.-J., Cho, Y., Lee, K.-N., Shin, D. W., Kim, Y. J., Yoon, J.-H., Han, K., & Yu, S. J. (2023). Gamma-glutamyl transferase and risk of all-cause and disease-specific mortality: a nationwide cohort study. Scientific Reports, 13(1), 1751. https://doi.org/10.1038/s41598-022-25970-0
2. Hanigan, M. H. (2026). Physiological role of gamma-glutamyl transpeptidase: Demise of the gamma-glutamyl cycle. Analytical Biochemistry, 713, 116087. https://doi.org/10.1016/j.ab.2026.116087
3. Wang, J., Zhang, D., Huang, R., Li, X., & Huang, W. (2017). Gamma-glutamyltransferase and risk of cardiovascular mortality: A dose-response meta-analysis of prospective cohort studies. PLoS ONE, 12(2), e0172631. https://doi.org/10.1371/journal.pone.0172631
4. Wannamethee, S. G., Shaper, A. G., Lennon, L., & Whincup, P. H. (2005). Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care, 28(12), 2913-2918. https://doi.org/10.2337/diacare.28.12.2913
5. Li, Y., Iso, H., Cui, R., Murakami, Y., Yatsuya, H., Miura, K., Nagasawa, S.-Y., Ueshima, H., & Okamura, T. (2016). Serum gamma-glutamyltransferase and mortality due to cardiovascular disease in Japanese men and women. Journal of Atherosclerosis and Thrombosis, 23(7), 792-799. https://doi.org/10.5551/jat.32698
6. Newsome, P. N., Cramb, R., Davison, S. M., Dillon, J. F., Foulerton, M., Godfrey, E. M., Hall, R., Harrower, U., Hudson, M., Langford, A., Mackie, A., Mitchell-Thain, R., Sennett, K., Sheron, N. C., Verne, J., Walmsley, M., & Yeoman, A. (2018). Guidelines on the management of abnormal liver blood tests. Gut, 67(1), 6-19. https://doi.org/10.1136/gutjnl-2017-314924
7. Kengne, A. P., Czernichow, S., Stamatakis, E., Hamer, M., & Batty, G. D. (2012). Gamma-glutamyltransferase and risk of cardiovascular disease mortality in people with and without diabetes: pooling of three British Health Surveys. Journal of Hepatology, 57(5), 1083-1089. https://doi.org/10.1016/j.jhep.2012.06.034
8. Liu, J., Au Yeung, S. L., Lin, S. L., Leung, G. M., & Schooling, C. M. (2016). Liver enzymes and risk of ischemic heart disease and type 2 diabetes mellitus: A Mendelian randomization study. Scientific Reports, 6, 38813. https://doi.org/10.1038/srep38813
9. Chambers, E. S., Byrne, C. S., Rugyendo, A., Morrison, D. J., Preston, T., Tedford, C., Bell, J. D., Thomas, L., Akbar, A. N., Riddell, N. E., Sharma, R., Thursz, M. R., Manousou, P., & Frost, G. (2019). The effects of dietary supplementation with inulin and inulin-propionate ester on hepatic steatosis in adults with non-alcoholic fatty liver disease. Diabetes, Obesity & Metabolism, 21(2), 372-376. https://doi.org/10.1111/dom.13500
10. Spencer, M. D., Hamp, T. J., Reid, R. W., Fischer, L. M., Zeisel, S. H., & Fodor, A. A. (2011). Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology, 140(3), 976-986. https://doi.org/10.1053/j.gastro.2010.11.049

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, board certified in anesthesiology, pain medicine, interventional pain management, addiction medicine and obesity medicine. Adapted from Chapter 5 of The Angry Gut by Dr. Padda and Ami Michelle Grimes. Last reviewed September 2026.